Increased cerebrospinal fluid levels of double-stranded rna-dependant protein kinase in alzheimer's disease

Biological Psychiatry

Volumn 71, Issue 9, 2012, Pages 829-835

  Mouton Liger, Franois ^a,b   Paquet, Claire ^a,b   Dumurgier, Julien ^a   Lapalus, Pauline ^a   Gray, Franoise ^a   Laplanche, Jean Louis ^a   Hugon, Jacques ^a,b  

^a SAINT LOUIS HOSPITAL   (France)

^b INSTITUT DU FER À MOULIN   (France)

Author keywords

Alzheimer's disease; biomarkers; cerebrospinal fluid; mild cognitive impairment; PKR; tau

Indexed keywords

AMYLOID BETA PROTEIN; PROTEIN KINASE R; TAU PROTEIN; THREONINE;

AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; CHEMICAL ANALYSIS; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NEUROLOGIC DISEASE; OPTICAL DENSITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN PHOSPHORYLATION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CELL LINE, TUMOR; DISEASE PROGRESSION; EIF-2 KINASE; FEMALE; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NERVOUS SYSTEM DISEASES; PEPTIDE FRAGMENTS; PHOSPHORYLATION; ROC CURVE; SENSITIVITY AND SPECIFICITY; TAU PROTEINS;

EID: 84859498356     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2011.11.031     Document Type: Article

References (38)

1. M.N. Rossor, N.C. Fox, C.J. Mummery, J.M. Schott, J.D. Warren The diagnosis of young-onset dementia Lancet Neurol 9 2010 793 806
2. C. Duyckaerts, B. Delatour, M.C. Potier Classification and basic pathology of Alzheimer disease Acta Neuropathol 118 2009 5 36
3. R.C. Petersen, R. Doody, A. Kurz, R.C. Mohs, J.C. Morris, P.V. Rabins Current concepts in mild cognitive impairment Arch Neurol 58 2001 1985 1992
4. J. Hardy, D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics Science 297 2002 353 356
5. J.W. Steele, S. Gandy Apomorphine and Alzheimer Aβ: Roles for regulated α cleavage, autophagy, and antioxidation? Ann Neurol 69 2011 221 225
6. K. Blennow, H. Hampel, M. Weiner, H. Zetterberg Cerebrospinal fluid and plasma biomarkers in Alzheimer disease Nat Rev Neurol 6 2010 131 144
7. B. Dubois, H.H. Feldman, C. Jacova, J.L. Cummings, S.T. Dekosky, P. Barberger-Gateau Revising the definition of Alzheimer's disease: A new lexicon Lancet Neurol 9 2010 1118 1127
8. B. Dubois, H.H. Feldman, C. Jacova, S.T. Dekosky, P. Barberger-Gateau, J. Cummings Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria Lancet Neurol 6 2007 734 746
9. G.M. McKhann, D.S. Knopman, H. Chertkow, B.T. Hyman, C.R. Jack Jr, C.H. Kawas The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 2011 263 269
10. T. Tapiola, I. Alafuzoff, S.K. Herukka, L. Parkkinen, P. Hartikainen, H. Soininen, T. Pirttila Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain Arch Neurol 66 2009 382 389
11. T. Grimmer, M. Riemenschneider, H. Forstl, G. Henriksen, W.E. Klunk, C.A. Mathis Beta amyloid in Alzheimer's disease: Increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid Biol Psychiatry 65 2009 927 934
12. J. Dumurgier, C. Paquet, S. Benisty, C. Kiffel, C. Lidy, F. Mouton-Liger Inverse association between CSF Abeta 42 levels and years of education in mild form of Alzheimer's disease: The cognitive reserve theory Neurobiol Dis 40 2010 456 459
13. W.J. Jagust, S.M. Landau, L.M. Shaw, J.Q. Trojanowski, R.A. Koeppe, E.M. Reiman Relationships between biomarkers in aging and dementia Neurology 73 2009 1193 1199
14. B.R. Williams PKR: A sentinel kinase for cellular stress Oncogene 18 1999 6112 6120
15. M.A. Garcia, E.F. Meurs, M. Esteban The dsRNA protein kinase PKR: virus and cell control Biochimie 89 2007 799 811
16. G.S. Hotamisligil Endoplasmic reticulum stress and the inflammatory basis of metabolic disease Cell 140 2010 900 917
17. T. Nakamura, M. Furuhashi, P. Li, H. Cao, G. Tuncman, N. Sonenberg Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis Cell 140 2010 338 348
18. R.C. Chang, A.K. Wong, H.K. Ng, J. Hugon Phosphorylation of eukaryotic initiation factor-2alpha (eIF2alpha) is associated with neuronal degeneration in Alzheimer's disease Neuroreport 13 2002 2429 2432
19. C. Paquet, F. Mouton-Liger, E.F. Meurs, P. Mazot, C. Bouras, L. Pradier The PKR activator PACT is induced by Aβ: Involvement in Alzheimer's disease [published online ahead of print July 25] Brain Pathol 2011 10.1111/j.1750-3639.2011.00520.x
20. R.C. Chang, K.C. Suen, C.H. Ma, W. Elyaman, H.K. Ng, J. Hugon Involvement of double-stranded RNA-dependent protein kinase and phosphorylation of eukaryotic initiation factor-2alpha in neuronal degeneration J Neurochem 83 2002 1215 1225
21. K.C. Suen, M.S. Yu, K.F. So, R.C. Chang, J. Hugon Upstream signaling pathways leading to the activation of double-stranded RNA-dependent serine/threonine protein kinase in beta-amyloid peptide neurotoxicity J Biol Chem 278 2003 49819 49827
22. G. Page, A. Rioux Bilan, S. Ingrand, C. Lafay-Chebassier, S. Pain, M.C. Perault Pochat Activated double-stranded RNA-dependent protein kinase and neuronal death in models of Alzheimer's disease Neuroscience 139 2006 1343 1354
23. R. Onuki, Y. Bando, E. Suyama, T. Katayama, H. Kawasaki, T. Baba An RNA-dependent protein kinase is involved in tunicamycin-induced apoptosis and Alzheimer's disease EMBO J 23 2004 959 968
24. A.L. Peel, D.E. Bredesen Activation of the cell stress kinase PKR in Alzheimer's disease and human amyloid precursor protein transgenic mice Neurobiol Dis 14 2003 52 62
25. A. Bose, F. Mouton-Liger, C. Paquet, P. Mazot, M. Vigny, F. Gray, J. Hugon Modulation of tau phosphorylation by the kinase PKR: Implications in Alzheimer's disease Brain Pathol 21 2011 189 200
26. G. Ill-Raga, E. Palomer, M.A. Wozniak, E. Ramos-Fernandez, M. Bosch-Morato, M. Tajes Activation of PKR causes amyloid ss-peptide accumulation via de-repression of BACE1 expression PLoS One 6 2011 e21456
27. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, E.M. Stadlan Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 1984 939 944
28. C. Paquet, A. Bose, M. Polivka, K. Peoc'h, J.P. Brouland, C. Keohane Neuronal phosphorylated RNA-dependent protein kinase in Creutzfeldt-Jakob disease J Neuropathol Exp Neurol 68 2009 190 198
29. E.R. DeLong, D.M. DeLong, D.L. Clarke-Pearson Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach Biometrics 44 1988 837 845
30. M.C. Yeung, J. Liu, A.S. Lau An essential role for the interferon-inducible, double-stranded RNA-activated protein kinase PKR in the tumor necrosis factor-induced apoptosis in U937 cells Proc Natl Acad Sci U S A 93 1996 12451 12455
31. C. Ballard, S. Gauthier, A. Corbett, C. Brayne, D. Aarsland, E. Jones Alzheimer's disease Lancet 377 2011 1019 1031
32. H.W. Querfurth, F.M. LaFerla Alzheimer's disease N Engl J Med 362 2010 329 344
33. E. Zotova, J.A. Nicoll, R. Kalaria, C. Holmes, D. Boche Inflammation in Alzheimer's disease: Relevance to pathogenesis and therapy Alzheimers Res Ther 2 2010 1
34. S.M. Kim, S.Y. Yoon, J.E. Choi, J.S. Park, J.M. Choi, T. Nguyen, D.H. Kim Activation of eukaryotic initiation factor-2 alpha-kinases in okadaic acid-treated neurons Neuroscience 169 2010 1831 1839
35. Y. Bando, R. Onuki, T. Katayama, T. Manabe, T. Kudo, K. Taira, M. Tohyama Double-strand RNA dependent protein kinase (PKR) is involved in the extrastriatal degeneration in Parkinson's disease and Huntington's disease Neurochem Int 46 2005 11 18
36. A.L. Peel, R.V. Rao, B.A. Cottrell, M.R. Hayden, L.M. Ellerby, D.E. Bredesen Double-stranded RNA-dependent protein kinase, PKR, binds preferentially to Huntington's disease (HD) transcripts and is activated in HD tissue Hum Mol Genet 10 2001 1531 1538
37. M. Paccalin, S. Pain-Barc, C. Pluchon, C. Paul, M.N. Besson, A.S. Carret-Rebillat Activated mTOR and PKR kinases in lymphocytes correlate with memory and cognitive decline in Alzheimer's disease Dement Geriatr Cogn Disord 22 2006 320 326
38. J. Hugon, C. Paquet, R.C. Chang Could PKR inhibition modulate human neurodegeneration? Expert Rev Neurother 9 2009 1455 1457